Stem cell patents final in US, debated in Europe

After three contentious stem cell patents were upheld in the US earlier this year, the debate over one of the patents continues this week in Europe. The Board of Appeal at the European Patent Office heard a dispute on Tuesday (June 24) on awarding a patent to the US stem cell technology. The technology in question is covered by one of the three patents held by the Wisconsin Alumni Research Foundation (WARF). It includes methods to culture and maintain primate embryonic stem cells derived from

Written byAndrea Gawrylewski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
After three contentious stem cell patents were upheld in the US earlier this year, the debate over one of the patents continues this week in Europe. The Board of Appeal at the European Patent Office heard a dispute on Tuesday (June 24) on awarding a patent to the US stem cell technology. The technology in question is covered by one of the three patents held by the Wisconsin Alumni Research Foundation (WARF). It includes methods to culture and maintain primate embryonic stem cells derived from pre-implantation embryos. This and the other two patents, covering human embryonic stem cells and replicating stem cells in culture, were upheld by the US Patent Office linkurl:this year.;http://www.the-scientist.com/templates/trackable/display/blog.jsp?type=blog&o_url=blog/display/54419&id=54419 James Thomson, University of Wisconsin researcher, and chief scientist behind the technology, is challenging the EPO's 2004 decision not to award a patent to this technology. "One of the main reasons for the refusal was that the disclosed method of obtaining stem cells used as the starting material a primate (including human) embryo which was destroyed in the process," the patent office said in a linkurl:news release;http://www.epo.org/topics/news/2008/20080617.html last week about the upcoming hearing. Justin Turner, the lawyer for WARF, told the Board of Appeal that EPO guidelines prevented patenting human embryos themselves, but not the cells derived from them, linkurl:The Earth Times reported.;http://www.earthtimes.org/articles/show/214619,european-patent-office-hears-dispute-on-human-stem-cells.html The board said it would make a ruling before the summer holidays. Meanwhile, WARF announced today that the US patent office has put the nail in the coffin of the examination process for two of the patents that were upheld by the agency in a final ruling last March. A new reexamination certificate issued by the USPTO on May 29 confirms that the patents, one of which is the one under debate in Europe, cannot be appealed. The third patent, covering the replication of stem cells in culture, which was upheld separately linkurl:earlier;http://www.the-scientist.com/blog/display/54389/ this year, can still be appealed. June 26, 2008: This blog has been updated from a previous version.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
December digest cover image of a wooden sculpture comprised of multiple wooden neurons that form a seahorse.
December 2025, Issue 1

Wooden Neurons: An Artistic Vision of the Brain

A neurobiologist, who loves the morphology of cells, turns these shapes into works of art made from wood.

View this Issue
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

Merck
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

MilliporeSigma purple logo
Abstract wireframe sphere with colorful dots and connecting lines representing the complex cellular and molecular interactions within the tumor microenvironment.

Exploring the Inflammatory Tumor Microenvironment 

Cellecta logo
An image of a DNA sequencing spectrum with a radial blur filter applied.

A Comprehensive Guide to Next-Generation Sequencing

Integra Logo

Products

brandtech logo

BRANDTECH® Scientific Announces Strategic Partnership with Copia Scientific to Strengthen Sales and Service of the BRAND® Liquid Handling Station (LHS) 

Top Innovations 2026 Contest Image

Enter Our 2026 Top Innovations Contest

Biotium Logo

Biotium Expands Tyramide Signal Amplification Portfolio with Brighter and More Stable Dyes for Enhanced Spatial Imaging

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS